中國健康科技集團(01069.HK)與健芝堂訂立戰略合作備忘錄
格隆匯5月13日丨中國健康科技集團(01069.HK)公告,於2025年5月13日,公司與黑龍江健芝堂生物科技有限公司訂立不具法律效力及約束力的戰略合作備忘錄,根據戰略合作備忘錄,雙方同意開展有關靈芝產品及保健品研發、銷售業務方面的合作。
健芝堂爲一家在中國成立的有限責任公司,專注於名貴藥材靈芝及保健食品的生產、加工、銷售及科研,屬一家集研發與經營於一體的生物科技企業。
根據戰略合作備忘錄,公司擬藉助健芝堂的技術及業務方面的優勢,拓展大健康產品的開發及銷售業務,從而提升公司業務的多樣性,並創造未來的利潤增長點。同時,公司亦可憑藉自身資金實力,與健芝堂在種植、生產及技術研發方面展開更深入的合作,並透過公司的市場渠道推動相關合作業務的市場推廣及銷售。
董事會認爲,公司與健芝堂簽署戰略合作備忘錄,將有利於集團發展靈芝及保健食品的研發及銷售業務。該業務發展可提升集團的財務表現及盈利能力,符合公司及其股東的整體利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.